Dr. Russell Sharp breaks down Hydrofarm’s latest results, falling sales, large write-downs and the company’s role as a barometer for the hydroponics and legal cannabis markets. The episode explores Hydrofarm’s brand portfolio, financial challenges, restructuring efforts and what the company’s struggles might mean for the wider hydroponic sector going forward. https://eutrema.co.uk/shop/fertiliser/liquid-gold-unique-complete-fertiliser/ nasdaq, new york stock exchange, london stock exchange
